Navigation Links
Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors
Date:10/12/2011

CRANBURY, N.J., Oct. 12, 2011 /PRNewswire/ -- Oncobiologics, Inc. announced today that is has named Scott Canute, a former President at both Eli Lilly and Genzyme, to its Board of Directors.  

Over the course of his 30-year career, Mr. Canute played a vital role in leading Eli Lilly's global manufacturing operations.  Most recently, he spent more than a year as President of Global Manufacturing and Corporate Operations for Genzyme, where he led a major turnaround effort.

"Scott Canute has been a distinguished leader at major biopharmaceutical organizations throughout his career," said Oncobiologics Founder & CEO Pankaj Mohan, Ph.D.  "I have known and admired Scott as my mentor for many years, and I am honored that he will share his experience and strategic insight to our efforts at Oncobiologics.  We look forward to guidance from Scott as a member of our board."

"Oncobiologics has assembled an impressive team of industry leaders, and already has developed a promising pipeline," said Mr. Canute.  "Although the company is a start-up, it has the horsepower of a much more established organization.  I look forward to helping Pankaj steer the company through this exciting stage."

Mr. Canute earned a Master of Business Administration from the Harvard Business School.  He also earned a B.S. in Chemical Engineering at the University of Michigan, where he graduated with Highest Honors.

About Oncobiologics, Inc.

Headquartered in Cranbury, N.J., Oncobiologics is utilizing a proprietary platform to develop a pipeline of next generation biotherapeutics focused on clinically validated targets in the therapeutic areas of oncology, immuno-oncology, and immunology. Oncobiologics provides world-class, turnkey proof-of-concept services that can take a partner's pre-clinical candidates from chemistry, manufacture and control development through Phase II clinical trials. For more information, pleas
'/>"/>

SOURCE Oncobiologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncobiologics, Inc. to Unveil New Biologics Proof-of-Concept Engine at BIO International Convention
2. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
3. Omeros Appoints David A. Mann to its Board of Directors
4. RainDance Technologies Appoints Olex Vice President, System Development
5. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
6. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
7. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
8. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
9. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
10. UltraShape Appoints Assaf Eyal as President & CEO
11. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Date: Friday, April 11, 2014 , ... Club, 1360 Almshouse Road, Warrington, Pa. , Details: ... dedicated to finding a cure for hepatitis B and improving ... its annual Crystal Ball on Friday, April 11 at Warrington ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, ... is an emerging biomedical company acquiring, developing, manufacturing, and ... , Free report download: http://equitiesiq.com/reports/alliqua/ , In ... team and Board, which launched the company’s new strategy ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
(Date:1/14/2014)... 14, 2014 During the 1600’s through the ... “The Doctor’s Plague.” In this time period, doctors did not ... at times, to the death of vulnerable patients. In the ... that they may be unwittingly transmitting herpes viruses to their ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... response to ever increasing,cardiac toxicity found in market drugs, ... new Cardionomics(TM) services,and the formation of its Cardionomics(TM) Advisory ... safety of drug candidates., Cardiac toxicity has played ... drugs over the past 30 years. It is estimated ...
... Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... Health Care Conference on Thursday, May 15, at ... live webcast of the,presentation on our website at:, ... log on 15 minutes early in order to,register ...
... SAN FRANCISCO, Calif., May 8 Anesiva,Inc. ... results and accomplishments,for the first quarter ended ... on its,commercialization activities for FDA-approved Zingo(TM) (lidocaine,hydrochloride ... as,clinical development milestones for Adlea(TM), the company,s ...
Cached Biology Technology:Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates 2Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates 3Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates 4Anesiva Announces First Quarter 2008 Financial Results 2Anesiva Announces First Quarter 2008 Financial Results 3Anesiva Announces First Quarter 2008 Financial Results 4Anesiva Announces First Quarter 2008 Financial Results 5Anesiva Announces First Quarter 2008 Financial Results 6Anesiva Announces First Quarter 2008 Financial Results 7Anesiva Announces First Quarter 2008 Financial Results 8
(Date:4/17/2014)... Kansas State University engineer has developed a patented ... improvised explosive devices. The same technique could help ... Steven M. and Kay L. Theede chair in ... engineering, and his research team have created a ... in car trunks. The distance detection method ...
(Date:4/17/2014)... German . If ... of him, he can expect his premises to be trashed. ... the consequences is enough to make restaurant owners pay up. ... their eggs in other birds, nests. If the host birds ... revenge by destroying the entire nest. Consequently, it is beneficial ...
(Date:4/17/2014)... in many serious conditions such as heart disease, epilepsy ... drug therapies. Unfortunately, there is still much scientists do ... fresh and unexpected insight into the structure of sodium ... molecules - which are responsible for ,fine-tuning, the activity ... most recent edition of the Journal of Biological ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3Structure of sodium channels different than previously believed 2
... the last dozen years, scientists have known that minuscule strings of ... makeup. But finding out what they do hasn,t been easy. Now ... a way to turn off small RNAs and find out just ... DNA is just the half of it. What we are is ...
... that specific types of RNA polymerase enzymes, the molecular machines ... on variation in the parts -- in this case protein ... findings on the synthesis and function of different RNA polymerases ... discovered over a decade ago -- the plant-specific enzymes Pol ...
... Curiosity has landed on Mars, a laser will fire a ... This will "ablate" or vaporize a microgram-sized piece of the ... will be analyzed by spectrometers to identify the target,s constituent ... even more. Researchers with the U.S. Department of Energy,s Lawrence ...
Cached Biology News:Turning off small RNA 2IU biologists offer clearer picture of how protein machine systems tweak gene expression 2LAMIS -- a green chemistry alternative for laser spectroscopy 2LAMIS -- a green chemistry alternative for laser spectroscopy 3LAMIS -- a green chemistry alternative for laser spectroscopy 4
... is a 12 amino acid synthetic peptide whose sequence is ... peptide is (amino to carboxy terminus): C - S(338) ... - Q - V - A - P - A(348). ... control experiments with the polyclonal antibody that reacts with this ...
... System more than doubles the benefits of ... fast analysis cycles of the standard binary ... in tandem mode. Difficult separations are dramatically ... or heartcut configurations, on-line sample preparation is ...
... this kit are prepared with pure chemicals ... Mitochondria Isolation Kit is designed to isolating ... and easy way. One kit is consisted ... (enriching mitochondria from 10 20 g ...
... Highly-purified, endotoxin-free plasmid DNA preparations ... plasmids in quantities from 1mg to ... well as large-scale (100mg-multi-gram) preparations are ... Each preparation is formulated according to ...
Biology Products: